Literature DB >> 4421567

Sensitivity of serum bile acid assay for detection of liver damage in viral hepatitis type B. Prospective study in five patients.

A F Hofmann, M G Korman, S Krugman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4421567     DOI： 10.1007/BF01076213

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN： 0002-9211


× No keyword cloud information.
  14 in total

1.  Bile acids in the serum of jaundiced patients.

Authors:  J B CAREY
Journal:  Gastroenterology       Date:  1961-09       Impact factor: 22.682

2.  Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection.

Authors:  S Krugman; J P Giles; J Hammond
Journal:  JAMA       Date:  1967-05-01       Impact factor: 56.272

3.  Assessment of activity in chronic active liver disease. Serum bile acids compared with conventional tests and histology.

Authors:  M G Korman; A F Hofmann; W H Summerskill
Journal:  N Engl J Med       Date:  1974-06-20       Impact factor: 91.245

4.  Viral hepatitis. New light on an old disease.

Authors:  S Krugman; J P Giles
Journal:  JAMA       Date:  1970-05-11       Impact factor: 56.272

5.  Radioimmunoassay of conjugated cholyl bile acids in serum.

Authors:  W J Simmonds; M G Korman; V L Go; A F Hofmann
Journal:  Gastroenterology       Date:  1973-11       Impact factor: 22.682

6.  [Gaschromatography studies of serum bile acids: methods as well as results in patients with acute hepatitis].

Authors:  W Erb; W E Schreiber; M Walczak
Journal:  Z Gastroenterol       Date:  1972       Impact factor: 2.000

7.  Viral hepatitis, type B (MS-2-strain). Further observations on natural history and prevention.

Authors:  S Krugman; J P Giles
Journal:  N Engl J Med       Date:  1973-04-12       Impact factor: 91.245

8.  Conjugated and unconjugated serum bile acid levels n patients with hepatobiliary diseases.

Authors:  I Makino; S Nakagawa; K Mashimo
Journal:  Gastroenterology       Date:  1969-06       Impact factor: 22.682

9.  Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody.

Authors:  C M Ling; L R Overby
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

10.  A complement-fixation test for measuring Australia antigen and antibody.

Authors:  R H Purcell; P V Holland; J H Walsh; D C Wong; A G Morrow; R M Chanock
Journal:  J Infect Dis       Date:  1969-09       Impact factor: 5.226
View more
  7 in total

1.  Serum bile salts as an aid to oral cholecystogram interpretation.

Authors:  R M Craig; M Caster; C Cochrane
Journal:  Dig Dis Sci       Date:  1979-08       Impact factor: 3.199

2.  Postprandial changes in serum concentrations of individual bile salts in normal subjects and patients with acute viral hepatitis.

Authors:  C B Campbell; C McGuffie; L W Powell; R K Roberts; A W Stewart
Journal:  Am J Dig Dis       Date:  1978-07

3.  Plasma clearance of oral and intravenous cholic acid in subjects with and without chronic liver disease.

Authors:  I T Gilmore; R P Thompson
Journal:  Gut       Date:  1980-02       Impact factor: 23.059

4.  Clinical significance of serum bile acid measurement in liver diseases.

Authors:  T Morita; Y Matsuyama; T Fujimoto; M Higuchi; T Tsujii; Y Matsuoka
Journal:  Gastroenterol Jpn       Date:  1978

5.  Radioimmunoassay of serum glycocholic acid, standard laboratory tests of liver function and liver biopsy findings: comparative study of children with liver disease.

Authors:  A Matsui; H T Psacharopoulos; A P Mowat; B Portmann; G M Murphy
Journal:  J Clin Pathol       Date:  1982-09       Impact factor: 3.411

6.  Diurnal serum levels of primary conjugated bile acids. Assessment by specific radioimmunoassays for conjugates of cholic and chenodeoxycholic acid.

Authors:  S W Schalm; N F LaRusso; A F Hofmann; N E Hoffman; G P van Berge-Henegouwen; M G Korman
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

7.  Glucuronidated and sulfated bile acids in serum of patients with acute hepatitis.

Authors:  H Takikawa; T Beppu; Y Seyama; T Sugimoto
Journal:  Dig Dis Sci       Date:  1986-05       Impact factor: 3.199
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.